The present meta-analysis included 8.139 cases and 14.116 controls from a total of 65 case-control studies about evaluating the diagnostic value of PCA3 in patients with PCa, and the detailed data of each study are listed in Table-1. This evidence concerns the gene PCA3 and posterior cortical atrophy.